NOTICE OF INTENT to Sole Source for Scientific Support Services for Generation and Multiomic Profiling of Induced Pluripotent Stem Cell-derived Neuronal Models

Closed Special Notice Posted

Solicitation number
75N95024R00104
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Special Notice is from the National Institute of Mental Health (NIMH), which is part of the Department of Health and Human Services' National Institutes of Health. The notice expresses NIMH's intent to award a sole source contract to Oxford StemTech Ltd. for Scientific Support Services related to the generation and multiomic profiling of induced pluripotent stem cell-derived neuronal models.

The purpose of this sole source procurement is to ensure that patient samples are processed in a manner consistent with the proprietary reprogramming, differentiation, and sequencing protocols used by NIMH's collaborators in the Section on Developmental Neurogenomics. The contract will have a 30-day delivery period and a 1-year period of performance from August 5, 2024 to August 4, 2025, with no options. NIMH has determined that Oxford StemTech Ltd. is the only vendor capable of providing these specialized services. Interested parties may submit capability statements, proposals, or quotations by July 29, 2024 at 12:00 PM EST, which will be considered to determine if the contract should proceed on a sole source or competitive basis.

Notice text

DESCRIPTION:

INTRODUCTION

This is a notice of intent, not a request for a quotation.

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute of Mental Health (NIMH) intends to negotiate on a sole source basis with the Oxford StemTech Ltd for Scientific Support Services for Generation and Multiomic Profiling of Induced Pluripotent Stem Cell-derived Neuronal Models.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS

The intended procurement is classified under NAICS code 541690 – Other Scientific and Technical Consulting Services with a Size Standard of $19.0 M.  

REGULATORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) Number 2024-05, dated April 22, 2024.

Delivery Date:  30 days ARO

Period of Performance:08/05/2024 – 08/04/2025

Option(s): None.

CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION

The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Oxford StemTech Ltd. is the only vendor in the marketplace that can provide the services  required by the National Institute of Mental Health (NIMH), Section on Developmental Neurogenomics.

The intended source is:

Oxford StemTech Ltd.

The Oxford Science Park

Edmund Hally Road

Oxford, UK, OX4 4GB

POC: Satyan Chintawar

Oxford StemTech Ltd.is the only source that can furnish the requirements, to the exclusion of other sources, because NIH must ensure patient samples are processed in a manner consistent with the uniquely derived control cells that have been reprogrammed, passaged, quality controlled, differentiated and sequenced according to a proprietary pipeline at Oxford StemTech. NIH is not able to use another provider for this service, because its collaborators in the Section on Developmental Neurogenomics (SDN) are using this pipeline to prepare cells that they will allow continuity for cellular reprogramming and differentiation protocols, as well as closely integrated quality control and bioinformatic pipelines. Having NIH’s cells processed by another provider would invalidate the resulting data.

CLOSING STATEMENT

THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest and capability to respond to this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity ID UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by the closing date and time of this announcement, July 29, 2024, at 12:00 PM EST, and must reference the solicitation number, 75N95024R00104.

Responses must be submitted electronically to Diedra S. Prophet, at diedra.prophet@nih.gov.

U.S. Mail and fax responses will not be accepted

Files

File Type Posted
NOTICE OF INTENT to Sole Source.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
iPSC Culture and Differentiation Bethesda, Maryland 20892, United States · NAICS 325414 Office of Logisitics and Acquisition Operations No set-aside
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - Extended Support Renewal for Dell Unity 400 Bethesda, Maryland 20892, United States · NAICS 33411 NIH Clinical Center No set-aside
Notice of Intent to Sole Source the Co-sponsorship of a Forum on Traumatic Brain Injury with the National Academies of Science, Engineering, and Medicine (NASEM) Maryland 21702, United States · NAICS 541715 — No set-aside
Intent to Sole Source - Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use) Bethesda, Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors